Exploring HCV genome to construct multi-epitope based subunit vaccine to battle HCV infection: Immunoinformatics based approach-Reference-Cited by-同舟云学术

Exploring HCV genome to construct multi-epitope based subunit vaccine to battle HCV infection: Immunoinformatics based approach

Published:2020-08 Issue: Volume:108 Page:103498
ISSN:1532-0464
Container-title:Journal of Biomedical Informatics
language:en
Short-container-title:Journal of Biomedical Informatics

Author:

Khalid Hina,Ashfaq Usman Ali^ORCID

Funder

Higher Education Commision, Pakistan

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference63 articles.

1. Discovery of novel hepatitis C virus NS5B polymerase inhibitors by combining random forest, multiple e-pharmacophore modeling and docking;Wei;PLoS ONE,2016

2. Resistance to direct antiviral agents in patients with hepatitis C virus infection;Sarrazin;Gastroenterology,2010

3. Kinetic and structural analyses of hepatitis C virus polyprotein processing;Bartenschlager;J. Virol.,1994

4. Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?;Walker;Curr. Opin. Immunol.,2015

5. Prospects for a vaccine against the hepatitis C virus;Houghton;Nature,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunoinformatic approach to design an efficient multi‐epitope peptide vaccine against melanoma;Biotechnology and Applied Biochemistry;2024-09-08

2. Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches;Journal of Medical Virology;2024-09

3. Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines;Biologicals;2024-08

4. Exploring the nuclear proteins, viral capsid protein, and early antigen protein using immunoinformatic and molecular modeling approaches to design a vaccine candidate against Epstein Barr virus;Scientific Reports;2024-07-22

5. Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1;3 Biotech;2024-06-05